Cite
Clinical and Pathophysiologic Insights of Free triiodothyronine/Free thyroxine Ratio in Patients with Heart Failure with Preserved Ejection Fraction: Data from the NETDiamond Cohort.
MLA
Leite, Ana Rita, et al. “Clinical and Pathophysiologic Insights of Free Triiodothyronine/Free Thyroxine Ratio in Patients with Heart Failure with Preserved Ejection Fraction: Data from the NETDiamond Cohort.” Cardiology, vol. 148, no. 3, 2023, pp. 239–45. EBSCOhost, https://doi.org/10.1159/000530136.
APA
Leite, A. R., Neves, J. S., Angélico-Gonçalves, A., Vasques-Nóvoa, F., Saraiva, F. A., Pinho, I. B., Oliveira, A. C., Borges-Canha, M., von Hafe, M., Vale, C., Lourenço, A. P., Macedo, F., Araújo, J. P., von Hafe, P., Almeida, J., Ferreira, J. P., & Leite-Moreira, A. (2023). Clinical and Pathophysiologic Insights of Free triiodothyronine/Free thyroxine Ratio in Patients with Heart Failure with Preserved Ejection Fraction: Data from the NETDiamond Cohort. Cardiology, 148(3), 239–245. https://doi.org/10.1159/000530136
Chicago
Leite, Ana Rita, João Sérgio Neves, António Angélico-Gonçalves, Francisco Vasques-Nóvoa, Francisca A Saraiva, Inês Beatriz Pinho, Ana Cristina Oliveira, et al. 2023. “Clinical and Pathophysiologic Insights of Free Triiodothyronine/Free Thyroxine Ratio in Patients with Heart Failure with Preserved Ejection Fraction: Data from the NETDiamond Cohort.” Cardiology 148 (3): 239–45. doi:10.1159/000530136.